News
CoolMed launch the CoolMed Portable Vaccine Carrier to help with the Covid vaccination roll-out
CoolMed, specialists in medical refrigeration, have strengthened their product offering with the launch of theCoolMed Portable Vaccine Carrier.
The carrier is designed to enable healthcare professionals to easily transport vaccines, solving the problem of cold chain compliance on the move...
Clinical Trials
Daiichi Sankyo begins phase 1 trial in Japan for nafamostat inhalation formulation to treat Covid-19
Daiichi Sankyo Company, Limited announced that it has initiated in Japan a first-in-human phase 1 trial for nafamostat inhalation formulation (DS-2319), which is being developed as a potential medicine for the treatment of the novel coronavirus infectious disease (hereinafter,...
News
Cold Chain Technologies Partners with B Medical Systems
Cold Chain Technologies announced that it is partnering with B Medical Systems, a Luxembourg-based manufacturer and global distributor of medical refrigeration and durable vaccine cold-chain technology. The partnership expands Cold Chain Technologies' portfolio to include hand-carry transport solutions as...
News
Ajinomoto Bio-Pharma Services Expands Manufacturing Agreement with AstraZeneca to Include Drug Product Manufacturing
Ajinomoto Bio-Pharma Services Cold Chain Technologies Partners with B Medical Systems , a leading provider of biopharmaceutical contract development and manufacturing services, is pleased to announce a manufacturing agreement expansion with AstraZeneca to include drug product manufacturing.
This agreement expands...
News
Johnson Announces Advance Purchase Agreement with the African Vaccine Acquisition Trust for the Companys COVID-19 Vaccine Candidate
Janssen Pharmaceutica NV, one of the Janssen Pharmaceutical Companies of Johnson & Johnson, has entered into an agreement with the African Vaccine Acquisition Trust (AVAT) to make available up to 220 million doses of its single-shot COVID-19 vaccine candidate...
Clinical Trials
Humanigen Reports Positive Phase 3 Topline Results Improves Survival Without Need for Mechanical Ventilation in Hospitalized Patients With COVID-19
Humanigen, Inc., a clinical-stage biopharmaceutical company focused on preventing and treating an immune hyper-response called ‘cytokine storm’ with its lead drug candidate, lenzilumab, today announced positive topline results from its Phase 3 clinical trial evaluating the efficacy and safety...
Clinical Trials
Foresee Pharma Announces Dosing of First Patient in Phase 2/3 Clinical Trial of FP-025 for Treatment of COVID-19 Associated ARDS
Foresee Pharmaceuticals Co., Ltd. announced the initiation of patient dosing in the Phase 2/3 clinical trial of FP-025, its highly selective oral MMP-12 inhibitor, in adult patients with severe to critical COVID-19 with associated Acute Respiratory Distress Syndrome (ARDS).
Dr....
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read